Discover how groundbreaking research on unique immune cells and advanced AI tools offers renewed hope for improving cancer ...

This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.

Patients with AML aged 80 years and older face poor survival despite treatment advances, highlighting the need for improved, ...

A 7-year-old in Idaho is at the forefront of many minds in the Lewisville area, as her family and community plan a fundraiser ...

The Food and Drug Administration (FDA) has approved Grafapex ™ (treosulfan) for injection with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation (alloHSCT) in ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with a broad ...

GTB-3650 is GT Biopharma's wholly owned second-generation TriKE. It utilizes camelid nanobody technology, with the potential ...

AMB-066 is a potential first-in-class treatment for CRC MRD ~20,000 patients diagnosed annually in U.S.; no currently approved therapies ...

StockNews.com initiated coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a research report released on Sunday. The firm issued a buy rating on the stock. MEI Pharma Price Performance ...

Ascentage Pharma’s U.S. IPO will support clinical testing of its two lead drugs, small molecules in development for advanced ...

The ACS has released cancer statistics for 2025 suggesting that more than 2 million new cases of cancer will be diagnosed in the US this year.

Researchers at the University of Colorado Anschutz Medical Campus found a promising therapeutic candidate that could aid in ...